User menu

Heterogeneous and Complex Rearragements of the Long Arm of Chromosome 6 in Chondromyxoid Fibroma

Bibliographic reference Romeo, S. ; Duim, R. A. J. ; Bridge, J. A. ; Mertens, F. ; de Jong, Daphne ; et. al. Heterogeneous and Complex Rearragements of the Long Arm of Chromosome 6 in Chondromyxoid Fibroma.99th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (Washington(Dc), Mar 20-26, 2010). In: Modern Pathology, Vol. 23, p. 27A (2010)
Permanent URL http://hdl.handle.net/2078.1/58763
  1. Mulligan Anna Marie, O??Malley Frances P., Papillary Lesions of the Breast : A Review, 10.1097/pap.0b013e318032508d
  2. Noguchi S, Am J Pathol, 144, 1320 (1994)
  3. Noguchi Shinzaburo, Aihara Tomohiko, Koyama Hiroki, Motomura Kazuyoshi, Inaji Hideo, Imaoka Shingi, Clonal analysis of benign and malignant human breast tumors by means of polymerase chain reaction, 10.1016/0304-3835(94)03678-c
  4. Tsuda Hitosmi, Takarabe Teruko, Inazawa Johji, Hirohashi Setsuo, Detection of numerical alterations of chromosomes 3, 7, 17 and X in low-grade intracystic papillary tumors of the breast by multi-color fluorescencein situ hybridization, 10.1007/bf02966515
  5. Lininger Ruth A., Park Won-Sang, Man Yan-Gao, Pham Thu, MacGrogan Gaetan, Zhuang Zhengping, Tavassoli Fatteneh A., Loh at 16p 13 is a novel chromosomal alteration detected in benign and malignant microdissected papillary neoplasms of the breast, 10.1016/s0046-8177(98)90422-1
  6. Cristofano Claudio Di, Mrad Karima, Zavaglia Katia, Bertacca Gloria, Aretini Paolo, Cipollini Giovanna, Bevilacqua Generoso, Romdhane Kaled Ben, Cavazzana Andrea, Papillary lesions of the breast: a molecular progression?, 10.1007/s10549-004-3003-3
  7. Boecker Werner, Buerger Horst, Schmitz Klaus, Ellis Ian A., van Diest Paul J., Sinn Hans-Peter, Geradts Joseph, Diallo Raihanatou, Poremba Christopher, Herbst Hermann, Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns, 10.1002/path.982
  8. Dietrich Claudia U., Pandis Nikos, Teixeira Manuel R., Bardi Georgia, Gerdes Anne-Marie, Andersen Johan A., Heim Sverre, Chromosome abnormalities in benign hyperproliferative disorders of epithelial and stromal breast tissue, 10.1002/ijc.2910600107
  9. Komoike Yoshifumi, Motomura Kazuyoshi, Inaji Hideo, Koyama Hiroki, Diagnosis of ductal carcinoma in situ (DCIS) and intraductal papilloma using fluorescence in Situ Hybridization (FISH) analysis, 10.1007/bf02966400
  10. Samuels Yardena, Velculescu Victor E., Oncogenic Mutations of PIK3CA in Human Cancers, 10.4161/cc.3.10.1164
  11. Dillon R L, White D E, Muller W J, The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer, 10.1038/sj.onc.1210202
  12. Bachman KE, Cancer Biol Ther, 3, 772 (2004)
  13. Lee Jong Woo, Soung Young Hwa, Kim Su Young, Lee Hae Woo, Park Won Sang, Nam Suk Woo, Kim Sang Ho, Lee Jung Young, Yoo Nam Jin, Lee Sug Hyung, PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas, 10.1038/sj.onc.1208304
  14. Li Shao Ying, Rong Minna, Grieu Fabienne, Iacopetta Barry, PIK3CA mutations in breast cancer are associated with poor outcome, 10.1007/s10549-005-9048-0
  15. Liang X, Cancer Biol Ther, 5, 544 (2006)
  16. Maruyama N., Miyoshi Y., Taguchi T., Tamaki Y., Monden M., Noguchi S., Clinicopathologic Analysis of Breast Cancers with PIK3CA Mutations in Japanese Women, 10.1158/1078-0432.ccr-06-0267
  17. Saal Lao H., Holm Karolina, Maurer Matthew, Memeo Lorenzo, Su Tao, Wang Xiaomei, Yu Jennifer S., Malmström Per-Olof, Mansukhani Mahesh, Enoksson Jens, Hibshoosh Hanina, Borg Åke, Parsons Ramon, PIK3CAMutations Correlate with Hormone Receptors, Node Metastasis, and ERBB2, and Are Mutually Exclusive with PTEN Loss in Human Breast Carcinoma, 10.1158/0008-5472-can-04-3913
  18. Perez-Tenorio G., Alkhori L., Olsson B., Waltersson M. A., Nordenskjold B., Rutqvist L. E., Skoog L., Stal O., PIK3CA Mutations and PTEN Loss Correlate with Similar Prognostic Factors and Are Not Mutually Exclusive in Breast Cancer, 10.1158/1078-0432.ccr-06-1609
  19. Stemke-Hale K., Gonzalez-Angulo A. M., Lluch A., Neve R. M., Kuo W.-L., Davies M., Carey M., Hu Z., Guan Y., Sahin A., Symmans W. F., Pusztai L., Nolden L. K., Horlings H., Berns K., Hung M.-C., van de Vijver M. J., Valero V., Gray J. W., Bernards R., Mills G. B., Hennessy B. T., An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer, 10.1158/0008-5472.can-07-6854
  20. Carpten John D., Faber Andrew L., Horn Candice, Donoho Gregory P., Briggs Stephen L., Robbins Christiane M., Hostetter Galen, Boguslawski Sophie, Moses Tracy Y., Savage Stephanie, Uhlik Mark, Lin Aimin, Du Jian, Qian Yue-Wei, Zeckner Douglas J., Tucker-Kellogg Greg, Touchman Jeffrey, Patel Ketan, Mousses Spyro, Bittner Michael, Schevitz Richard, Lai Mei-Huei T., Blanchard Kerry L., Thomas James E., A transforming mutation in the pleckstrin homology domain of AKT1 in cancer, 10.1038/nature05933
  21. Kim M S, Jeong E G, Yoo N J, Lee S H, Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias, 10.1038/sj.bjc.6604212
  22. Hennessy Bryan T., Smith Debra L., Ram Prahlad T., Lu Yiling, Mills Gordon B., Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery, 10.1038/nrd1902
  23. Wymann Matthias P, Marone Romina, Phosphoinositide 3-kinase in disease: timing, location, and scaffolding, 10.1016/j.ceb.2005.02.011
  24. Zhao L, Vogt P K, Class I PI3K in oncogenic cellular transformation, 10.1038/onc.2008.244
  25. Page David L., Rogers Lowell W., Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia, 10.1016/0046-8177(92)90026-y
  26. Collins LC, Histopathology, 52, 20 (2008)
  27. Maluf HM, Am J Surg Pathol, 19, 1237 (1995)
  28. Pratilas C. A., Hanrahan A. J., Halilovic E., Persaud Y., Soh J., Chitale D., Shigematsu H., Yamamoto H., Sawai A., Janakiraman M., Taylor B. S., Pao W., Toyooka S., Ladanyi M., Gazdar A., Rosen N., Solit D. B., Genetic Predictors of MEK Dependence in Non-Small Cell Lung Cancer, 10.1158/0008-5472.can-08-2223
  29. Ma X.-J., Salunga R., Tuggle J. T., Gaudet J., Enright E., McQuary P., Payette T., Pistone M., Stecker K., Zhang B. M., Zhou Y.-X., Varnholt H., Smith B., Gadd M., Chatfield E., Kessler J., Baer T. M., Erlander M. G., Sgroi D. C., Gene expression profiles of human breast cancer progression, 10.1073/pnas.0931261100
  30. Reis-Filho Jorge S, Lakhani Sunil R, The diagnosis and management of pre-invasive breast disease Genetic alterations in pre-invasive lesions, 10.1186/bcr650
  31. Burstein Harold J., Polyak Kornelia, Wong Julia S., Lester Susan C., Kaelin Carolyn M., Ductal Carcinoma in Situ of the Breast, 10.1056/nejmra031301
  32. Simpson Peter T, Reis-Filho Jorge S, Gale Theodora, Lakhani Sunil R, Molecular evolution of breast cancer, 10.1002/path.1691
  33. Arpino Grazia, Laucirica Rodolfo, Elledge Richard M., Premalignant and In Situ Breast Disease: Biology and Clinical Implications, 10.7326/0003-4819-143-6-200509200-00009
  34. Moulis Sharon, Sgroi Dennis C, Re-evaluating early breast neoplasia, 10.1186/bcr1853
  35. Samuels Y., High Frequency of Mutations of the PIK3CA Gene in Human Cancers, 10.1126/science.1096502
  36. Isakoff Steven J., Engelman Jeffrey A., Irie Hanna Y., Luo Ji, Brachmann Saskia M., Pearline Rachel V., Cantley Lewis C., Brugge Joan S., Breast Cancer–AssociatedPIK3CAMutations Are Oncogenic in Mammary Epithelial Cells, 10.1158/0008-5472.can-05-2612
  37. Ikenoue Tsuneo, Kanai Fumihiko, Hikiba Yohko, Obata Toshiyuki, Tanaka Yasuo, Imamura Jun, Ohta Miki, Jazag Amarsanaa, Guleng Bayasi, Tateishi Keisuke, Asaoka Yoshinari, Matsumura Masayuki, Kawabe Takao, Omata Masao, Functional Analysis of PIK3CA Gene Mutations in Human Colorectal Cancer, 10.1158/0008-5472.can-04-4114
  38. O'Connell Peter, Pekkel Vladimir, Allred D. Craig, Fuqua Suzanne A. W., Osborne C. Kent, Clark Gary M., Analysis of Loss of Heterozygosity in 399 Premalignant Breast Lesions at 15 Genetic Loci, 10.1093/jnci/90.9.697
  39. Werner M., Mattis Anita, Aubele Michaela, Cummings Margaret, Zitzelsberger Horst, Hutzler Peter, Höfler Heinz, 20q13.2 Amplification in intraductal hyperplasia adjacent to in situ and invasive ductal carcinoma of the breast, 10.1007/s004280050429
  40. Aubele Michaela M., Cummings Margaret C., Mattis Anita E., Zitzelsberger Horst F., Walch Axel K., Kremer Markus, Höfler Heinz, Werner Martin, Accumulation of Chromosomal Imbalances From Intraductal Proliferative Lesions to Adjacent In Situ and Invasive Ductal Breast Cancer : , 10.1097/00019606-200003000-00003
  41. Allred D., Histological and biological evolution of human premalignant breast disease, 10.1677/erc.0.0080047
  42. Gong G, Clin Cancer Res, 7, 2410 (2001)
  43. Jones Chris, Merrett Samantha, Thomas Valerie A, Barker Tim H, Lakhani Sunil R, Comparative genomic hybridization analysis of bilateral hyperplasia of usual type of the breast, 10.1002/path.1280
  44. Yu Qi, Niu Yun, Yu Yong, Ding XiuMin, Shi YuRong, Analysis of the progression of intraductal proliferative lesions in the breast by PCR-based clonal assay, 10.1007/s10549-008-0029-y
  45. Malaney Suzann, Daly Roger J., 10.1023/a:1009572700317
  46. Karnoub Antoine E., Weinberg Robert A., Ras oncogenes: split personalities, 10.1038/nrm2438
  47. Esposito Nicole Nicosia, Dabbs David J, Reply to Bratthauer, Wheeler and Tavassoli, 10.1038/modpathol.2008.24